296 related articles for article (PubMed ID: 9732918)
1. Nonsteroidal antiinflammatory drug use and gallstone disease prevalence: a case-control study.
Pazzi P; Scagliarini R; Sighinolfi D; Govoni M; La Corte R; Gullini S
Am J Gastroenterol; 1998 Sep; 93(9):1420-4. PubMed ID: 9732918
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
Acalovschi M; Blendea D; Feier C; Letia AI; Ratiu N; Dumitrascu DL; Veres A
Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease.
Lapidus A; Bångstad M; Aström M; Muhrbeck O
Am J Gastroenterol; 1999 May; 94(5):1261-6. PubMed ID: 10235204
[TBL] [Abstract][Full Text] [Related]
4. Gallstone prevalence in Christchurch: risk factors and clinical significance.
Chapman BA; Frampton CM; Wilson IR; Chisholm RJ; Allan RB; Burt MJ
N Z Med J; 2000 Feb; 113(1104):46-8. PubMed ID: 10777222
[TBL] [Abstract][Full Text] [Related]
5. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis.
Popat RA; Tanner CM; van den Eeden SK; Bernstein AL; Bloch DA; Leimpeter A; McGuire V; Nelson LM
Amyotroph Lateral Scler; 2007 Jun; 8(3):157-63. PubMed ID: 17538777
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
7. Gallstone disease and related risk factors in a large cohort of diabetic patients.
Pagliarulo M; Fornari F; Fraquelli M; Zoli M; Giangregorio F; Grigolon A; Peracchi M; Conte D
Dig Liver Dis; 2004 Feb; 36(2):130-4. PubMed ID: 15002821
[TBL] [Abstract][Full Text] [Related]
8. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
9. No association between gallstones and gastroesophageal reflux disease.
Avidan B; Sonnenberg A; Schnell TG; Sontag SJ
Am J Gastroenterol; 2001 Oct; 96(10):2858-62. PubMed ID: 11693317
[TBL] [Abstract][Full Text] [Related]
10. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
[TBL] [Abstract][Full Text] [Related]
11. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population.
Rahme E; Pettitt D; LeLorier J
Arthritis Rheum; 2002 Nov; 46(11):3046-54. PubMed ID: 12428249
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO).
Am J Epidemiol; 1984 May; 119(5):796-805. PubMed ID: 6720676
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of gallstone disease in patients with diabetes mellitus. A case-control study.
Persson GE; Thulin AJ
Eur J Surg; 1991 Oct; 157(10):579-82. PubMed ID: 1687247
[TBL] [Abstract][Full Text] [Related]
14. Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.
Loria P; Lonardo A; Lombardini S; Carulli L; Verrone A; Ganazzi D; Rudilosso A; D'Amico R; Bertolotti M; Carulli N
J Gastroenterol Hepatol; 2005 Aug; 20(8):1176-84. PubMed ID: 16048564
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
Hepatology; 1988; 8(4):907-13. PubMed ID: 3391520
[TBL] [Abstract][Full Text] [Related]
16. Risk of gallstone disease is associated with serum level of alpha-1-acid glycoprotein.
Thijs CT; Groen AK; Hovens M; Mok KS
Epidemiology; 1999 Nov; 10(6):764-6. PubMed ID: 10535793
[TBL] [Abstract][Full Text] [Related]
17. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.
Mosis G; Stijnen T; Castellsague J; Dieleman JP; van der Lei J; Stricker BH; Sturkenboom MC
Arthritis Rheum; 2006 Aug; 55(4):537-42. PubMed ID: 16874797
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for gallstone disease in patients with gallstones having gallstone heredity. A case-control study.
Tîrziu S; Bel S; Bondor CI; Acalovschi M
Rom J Intern Med; 2008; 46(3):223-8. PubMed ID: 19366081
[TBL] [Abstract][Full Text] [Related]
19. Incidence of gallstones in chronic renal failure patients undergoing hemodialysis: experience of a center in Turkey.
Altiparmak MR; Pamuk ON; Pamuk GE; Celik AF; Apaydin S; Cebi D; Mihmanli I; Erek E
Am J Gastroenterol; 2003 Apr; 98(4):813-20. PubMed ID: 12738461
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol.
Buchner AM; Sonnenberg A
Am J Gastroenterol; 2002 Apr; 97(4):905-9. PubMed ID: 12003426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
